But the appeals court allowed separate elements of Kacsmaryk’s decision

The appeals court had somewhat narrowed the scope of an even broader ruling issued April 7 by Texas-based U.S. District Judge Matthew Kacsmaryk. The 5th Circuit declined to suspend the original FDA approval of mifepristone in 2000, as Kacsmaryk had ruled, which would have made distributing it unlawful.คาสิโนไทย